We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Revolutionary Blood Test to Transform Early Diagnosis of Bowel Cancer

By LabMedica International staff writers
Posted on 20 May 2022

Bowel (colorectal) cancer is the second most common cancer globally. More...

It is the leading cause of cancer-related death in the Western world. Early diagnosis of bowel cancer significantly reduces mortality rate. Current diagnostics tests such as colonoscopy or fecal blood detection kits can be invasive, unpleasant and expensive. Now, an accurate, non-invasive, inexpensive blood test can diagnose bowel cancer early and dramatically cut waiting times for diagnosis while reducing the need for unnecessary invasive procedures such as colonoscopies.

Researchers at Swansea University (Swansea, UK) have devised a simple Raman Spectrometry (RS) blood test which can return test results in under 20 minutes. Using innovations based around laser spectroscopy and artificial intelligence (AI) -based analytics, the test analyses cancer-driven metabolic activity in blood that their AI software is trained to interpret and diagnose. The test aims to break down patient anxiety with a highly accurate test to give rapid reassurance to those who have not got cancer and ensure they do not need an invasive colonoscopy. As a result, this will free up valuable endoscopy and colonoscopy resource and speed up treatment for those who have cancer while resulting in savings from a reduction of needless colonoscopies.

Results from a ground-breaking study involving 27 practices and 595 patients showed 79% of early-stage bowel cancers and 100% of advanced bowel cancers were picked up by the test. Early comparisons with other tests currently available in primary care have shown the RS blood test to have greater sensitivity for the detection of bowel cancer. Currently, a high number of unnecessary colonoscopies are conducted to ensure cases of bowel cancer are detected. Since the start of the pandemic, waiting lists for the procedure have significantly increased. These delays can reduce the chances of patient survival, with many people being diagnosed too late. The blood test hopes to change all that by providing accurate results within 48 hours, preventing unnecessary colonoscopies and relieving pressure on healthcare systems.

Related Links:
Swansea University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image: The automated IHC assay helps identify mesothelioma and distinguish it from other malignancies, including NSCLC. (Image Credit: Shutterstock)

Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis

Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more

Technology

view channel
Image: Diatech Pharmacogenetics launches Labcycler, a compact PCR thermal cycler. (Photo courtesy of Diatech Pharmacogenetics)

Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows

Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.